Search research articles
Contact Us
Filters
Showing results (371-380 of 393) with videos related to
Page
of 40
Sort By:
Blood
|
September 17, 2017
Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels
Michelle Lavin, Sonia Aguila, Sonja Schneppenheim, et al.
Blood
|
February 17, 2019
Increased galactose expression and enhanced clearance in patients with low von Willebrand factor
Sonia Aguila, Michelle Lavin, Niall Dalton, et al.
Blood Advances
|
September 29, 2023
VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion
Helen Fogarty, Azaz Ahmad, Ferdows Atiq, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2016
Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors
Neil S Garton, Michael D Barker, Rob P Davis, et al.
Nature Communications
|
September 23, 2021
Identification of the factor XII contact activation site enables sensitive coagulation diagnostics
Marco Heestermans, Clément Naudin, Reiner K Mailer, et al.
Science Advances
|
March 7, 2025
Trained immunity causes myeloid cell hypercoagulability
Aisling M Rehill, Seán McCluskey, Anna E Ledwith, et al.
The Journal of Clinical Investigation
|
April 26, 2014
The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation
Ming Yan, Marie-Claude Gingras, Elaine A Dunlop, et al.
Nature Communications
|
November 4, 2022
von Willebrand factor links primary hemostasis to innate immunity
Clive Drakeford, Sonia Aguila, Fiona Roche, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 10, 2021
Persistent endotheliopathy in the pathogenesis of long COVID syndrome
Helen Fogarty, Liam Townsend, Hannah Morrin, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 25, 2022
Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction
Helen Fogarty, Soracha E Ward, Liam Townsend, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 393) with videos related to
Sort By:
Page
of 40
Blood
|
September 17, 2017
Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels
Michelle Lavin, Sonia Aguila, Sonja Schneppenheim, et al.
Blood
|
February 17, 2019
Increased galactose expression and enhanced clearance in patients with low von Willebrand factor
Sonia Aguila, Michelle Lavin, Niall Dalton, et al.
Blood Advances
|
September 29, 2023
VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion
Helen Fogarty, Azaz Ahmad, Ferdows Atiq, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2016
Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors
Neil S Garton, Michael D Barker, Rob P Davis, et al.
Nature Communications
|
September 23, 2021
Identification of the factor XII contact activation site enables sensitive coagulation diagnostics
Marco Heestermans, Clément Naudin, Reiner K Mailer, et al.
Science Advances
|
March 7, 2025
Trained immunity causes myeloid cell hypercoagulability
Aisling M Rehill, Seán McCluskey, Anna E Ledwith, et al.
The Journal of Clinical Investigation
|
April 26, 2014
The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation
Ming Yan, Marie-Claude Gingras, Elaine A Dunlop, et al.
Nature Communications
|
November 4, 2022
von Willebrand factor links primary hemostasis to innate immunity
Clive Drakeford, Sonia Aguila, Fiona Roche, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 10, 2021
Persistent endotheliopathy in the pathogenesis of long COVID syndrome
Helen Fogarty, Liam Townsend, Hannah Morrin, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 25, 2022
Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction
Helen Fogarty, Soracha E Ward, Liam Townsend, et al.
Page
of 40